(Q34706719)

4 August 2017

title

Value of black blood T2* cardiovascular magnetic resonance (English)

1 reference

4 August 2017

1 reference

6

Dudley J Pennell

1 reference

4 August 2017

5

David N Firmin

1 reference

4 August 2017

Gillian C Smith

1

1 reference

4 August 2017

John Paul Carpenter

series ordinal

2

1 reference

4 August 2017

Taigang He

series ordinal

3

1 reference

4 August 2017

Mohammed H Alam

series ordinal

4

1 reference

4 August 2017

publication date

14 March 2011

1 reference

Journal of Cardiovascular Magnetic Resonance

4 August 2017

published in

1 reference

4 August 2017

volume

13

1 reference

4 August 2017

page(s)

21

1 reference

https://scigraph.springernature.com/pub.10.1186/1532-429x-13-21

4 August 2017

exact match

0 references

cites work

International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062187

Update on survival in thalassemia major

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062187

Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062187

Myocardial T2* measurements in iron-overloaded thalassemia: An in vivo study to investigate optimal methods of quantification

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062187

Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062187

A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062187

Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062187

Improved R2* measurements in myocardial iron overload

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062187

Breath-hold FLASH and FISP cardiovascular MR imaging: left ventricular volume differences and reproducibility

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062187

In vivo measurement of T*2 and field inhomogeneity maps in the human heart at 1.5 T.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062187

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062187

Survival and desferrioxamine in thalassaemia major.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062187

Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062187

A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload.

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1532-429X-13-21

Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1532-429X-13-21

Black-blood T2* technique for myocardial iron measurement in thalassemia.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1532-429X-13-21

Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062187

Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21401929

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1532-429X-13-21

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference